Press Release:  Fluent BioSciences expands access to industry’s most flexible and scalable technology (PIPseq) to enable single-cell analysis in any laboratory

News

Fluent BioSciences expands access to industry’s most flexible and scalable technology (PIPseq) to enable sensitive single-cell transcriptome analysis in any laboratory

Watertown, MA., May 5, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced expanded early access to two new products for 3′ single-cell RNA analysis. Scaled to efficiently and effectively meet diverse experimental demands, PIPseqTM T2 and T20 kits capture up to 2,000 and 20,000 […]

Read More

Fluent BioSciences awarded $1.7 Million SBIR grant to commercialize PIPseq™ a breakthrough platform technology enabling scalable, sensitive single-cell analysis in any laboratory

Funding will be used to support commercialization of single-cell RNA sequencing (scRNA-Seq) products and services to address the critical need for accessibility, affordability and scalability. Watertown, MA., March 9, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced today that it has been awarded a […]

Read More

Meet Fluent BioSciences at the ASHG Virtual Meeting (Oct 18-22, 2021)

Fluent BioSciences will be attending the American Society of Human Genetics (ASHG) virtual meeting and presenting three posters showcasing our technology and single cell RNA sequencing applications data from early customers. Attend to learn more about our technology and upcoming products.

Read More